Defib database
This article was originally published in The Gray Sheet
Executive Summary
ICD Registry Working Group will hold meetings through Nov. 30 to generate recommendations for CMS on designing and implementing a national registry of implantable cardioverter defibrillators. The registry will be created as a condition of CMS' proposed ICD coverage decision, issued Sept. 28. Under the decision, participation in a national ICD registry is required for reimbursement. Representatives from the Heart Rhythm Society will lead the group, which also includes reps from St. Jude Medical, Guidant, Medtronic, the American College of Cardiology, the Heart Failure Society of America, Duke Clinical Research Institute, University of Pittsburgh and Indiana University...
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.